Morgan Stanley Knock-Out OMV/ DE000MA3WNK3 /
15/11/2024 17:39:31 | Chg.+0.04 | Bid22:00:35 | Demandez à22:00:35 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
1.66EUR | +2.47% | - Bid taille: - |
- Ask la taille: - |
OMV AG | 21.9043 - | 31/12/2078 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page